RETINALGENIX TECHNOLOGIES INC. 2017 EQUITY INCENTIVE PLAN [as of December 1, 2017]RetinalGenix Technologies Inc. • June 28th, 2021 • Surgical & medical instruments & apparatus • Delaware
Company FiledJune 28th, 2021 Industry Jurisdiction
OPTION EXCHANGE AGREEMENTOption Exchange Agreement • June 28th, 2021 • RetinalGenix Technologies Inc. • Surgical & medical instruments & apparatus • New Jersey
Contract Type FiledJune 28th, 2021 Company Industry JurisdictionThis OPTION EXCHANGE AGREEMENT, dated as of October 8, 2019 (this “Agreement”), by and between RETINALGENIX TECHNOLOGIES, INC., a Delaware corporation having an address of P.O. 2129 San Rafael, California 94912 (“RG”) and DIOPSYS, INC., a Delaware corporation having an address at 16 Chapin Road, Suite 911-912, Pine Brook, New Jersey 07058 (“DIOPSYS”). For purposes of this Agreement RG and DIOPSYS are sometimes collectively referred to as the “Parties” and individually as a “Party.”
AMENDED AND RESTATED MASTER SERVICES AGREEMENTMaster Services • June 28th, 2021 • RetinalGenix Technologies Inc. • Surgical & medical instruments & apparatus • New Jersey
Contract Type FiledJune 28th, 2021 Company Industry JurisdictionTHIS AMENDED AND RESTATED AGREEMENT (this “Agreement”), is made and entered into on this 24th day of June 2021, retroactive to the 13th day of December 2019, by and between ADM Tronics Unlimited, Inc., with offices located at 224S Pegasus Ave., Northvale, NJ 07647 (“ADMT”) and RetinalGenix Technologies Inc., with offices located at 1450 North McDowell Blvd., Suite 150, Petaluma, CA 94954 (the “Client”).